Cystic papillary pattern in pancreatic ductal adenocarcinoma: A heretofore undescribed morphologic pattern that mimics intraductal papillary mucinous carcinoma

American Journal of Surgical Pathology

Volumn 36, Issue 5, 2012, Pages 696-701

  Kelly, Paul J ^a   Shinagare, Shweta ^b   Sainani, Nisha ^c   Hong, Xiao ^b   Ferrone, Cristina ^b   Yilmaz, Omer ^b   Fernández Del Castillo, Carlos ^b   Lauwers, Gregory Y ^b   Deshpande, Vikram ^b  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cystic papillary pattern; intraductal papillary mucinous neoplasm; pancreatic ductal adenocarcinoma

Indexed keywords

TUMOR MARKER;

ADENOCARCINOMA; AGED; ARTICLE; COLLOID CARCINOMA; CYSTADENOCARCINOMA; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; RETROSPECTIVE STUDY;

ADENOCARCINOMA, MUCINOUS; ADENOCARCINOMA, PAPILLARY; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CYSTADENOCARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84859885195     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318249ce1c     Document Type: Article

References (12)

1. Basturk O, Khayyata S, Klimstra DS, et al. Preferential expression of MUC6 in oncocytic and pancreatobiliary types of intraductal papillary neoplasms highlights a pyloropancreatic pathway, distinct from the intestinal pathway, in pancreatic carcinogenesis. Am J Surg Pathol. 2010;34:364-370.
2. Fernandez-del Castillo C, Adsay NV. Intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology. 2010;139: 708-713, 713, e1-2.
3. Furukawa T, Kloppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: aconsensus study. Virchows Arch. 2005;447:794-799. (Pubitemid 41728866)
4. Hruban RH, Fukushima N. Pancreatic adenocarcinoma: update on the surgical pathology of carcinomas of ductal origin and PanINs.Mod Pathol. 2007;20(suppl 1):S61-S70. (Pubitemid 46733656)
5. Iacobuzio-Donahue CA, Klimstra DS, Adsay NV, et al. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. Am J Pathol. 2000;157:755-761. (Pubitemid 32109368)
6. Kosmahl M, Pauser U, Anlauf M, et al. Pancreatic ductal adenocarcinomas with cystic features: neither rare nor uniform. Mod Pathol. 2005;18:1157-1164. (Pubitemid 43079914)
7. Luttges J, Zamboni G, Longnecker D, et al. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol. 2001;25:942-948. (Pubitemid 32594989)
8. Maire F, Hammel P, Terris B, et al. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut. 2002;51:717-722. (Pubitemid 35216862)
9. Nara S, Shimada K, Kosuge T, et al. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms. Am J Surg Pathol. 2008;32:243-255. (Pubitemid 351172139)
10. Wilentz RE, Su GH, Dai JL, et al. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of DPC4 inactivation. Am J Pathol. 2000;156:37-43. (Pubitemid 30644436)
11. Yamaguchi H, Shimizu M, Ban S, et al. Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelialneoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2009;33:1164-1172.
12. Yamaguchi K, Kanemitsu S, Hatori T, et al. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas. 2011;40:571-580.